Elsevier Inc.

SHERPA: Unknown

People

  1. Giralt
    Giralt
  2. Perales
    Perales
  3. Devlin
    Devlin
  4. O'Reilly
    O'Reilly
  5. Jakubowski
    Jakubowski
  6. Park
    Park
  7. Van Den Brink
    Van Den Brink
  8. Levine
    Levine
  9. Papadopoulos
    Papadopoulos
  10. Shah
    Shah

Groups

  1. Adult Leukemia (39)
  2. Center for Hematologic Malignancies (39)
  3. Department of Medicine (39)
  4. Hematologic Malignancies, Division of (39)
  5. GSK Faculty (22)
  6. Bone Marrow Transplant (21)
  7. Sloan Kettering Institute Faculty (13)
  8. Epidemiology and Biostatistics (12)
  9. Executive Committee, Center for Hematologic Malignancies (12)
  10. Immunology Program Faculty (12)
Search Within
  1. "Adult Leukemia"
  2. "Biology of Blood and Marrow Transplantation"
Formats
  1. Meeting Abstract (19)
  2. Journal Article (18)
  3. Guidelines (1)
  4. Review (1)
Groups
  1. Adult Leukemia (39)
  2. Center for Hematologic Malignancies (39)
  3. Department of Medicine (39)
  4. Hematologic Malignancies, Division of (39)
  5. GSK Faculty (22)
  6. Bone Marrow Transplant (21)

More Groups

People
  1. Martin Tallman (17)
  2. Miguel-Angel Perales (15)
  3. Sergio Giralt (15)
  4. Molly Maloy (10)
  5. Sean Devlin (10)
  6. Jae Park (8)

More People

Years
  1. 2020 (5)
  2. 2019 (10)
  3. 2018 (8)
  4. 2017 (4)
  5. 2016 (1)
  6. 2015 (3)

More Years

Publications
  1. Biology of Blood and Marrow Transplantation (39)

Results (39)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Trial in progress: A phase 2, single-arm, open-label study of itacitinib (ITA) for the prevention of chimeric antigen receptor (CAR) T-cell-induced cytokine release syndrome (CRS)
    Meeting Abstract

    Park, J. H.; Frigault, M. J.; Maziarz, R. T.; Nairn, A.; Burke, L.; Tian, C.; Porters, D. L.
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Durable remission following "off-the-shelf" chimeric antigen receptor (CAR) T-cells in patients with relapse/refractory (R/R) B-cell malignancies
    Meeting Abstract

    Curran, K. J.; Sauter, C. S.; Kernan, N. A.; Prockop, S. E.; Boulad, F.; Perales, M.; Giralt, S. A.; Riviere, I.; Wang, X.; Boelens, J. J.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Hematopoietic recovery following chimeric antigen receptor T cell (CAR T) therapy in hematological malignancies
    Meeting Abstract

    Jain, T.; Knezevic, A.; Pennisi, M.; Ruiz, J. D.; Devlin, S. M.; Halton, E.; Diamonte, C.; Scordo, M.; Sauter, C. S.; Mead, E.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Comparing car T cells toxicities grading systems: Application of ASTCT grading system and implications for management
    Meeting Abstract

    Pennisi, M.; Jain, T.; Mead, E.; Santomasso, B.; Silverberg, M. L.; Batlevi, Y.; Shouval, R.; Devlin, S. M.; Batlevi, C. W.; Brentjens, R.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • MLL-rearranged AML is associated with poor outcomes as compared to patients with intermediate- and adverse-risk disease: A CIBMTR study of 3779 adult patients
    Meeting Abstract

    Menghrajani, K.; Zhang, M. J.; Bo-Subait, K.; Wang, H. L.; Devlin, S. M.; Madero-Marroquin, R.; Gomez Arteaga, A.; Sandmaier, B. M.; Litzow, M. R.; Kebriaei, P.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Thirty day resource utilization after chimeric antigen receptor (CAR) T cell infusion for hematologic malignancies
    Meeting Abstract

    Shah, G. L.; Park, J.; Sauter, C. S.; Duck, E.; Halton, E.; Batlevi, C. W.; Palomba, M. L.; Younes, A.; Geyer, M. B.; Smith, E.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Intestinal microbiome analyses identify biomarkers for patient response to CAR T cell therapy
    Meeting Abstract

    Smith, M.; Littmann, E.; Slingerland, J.; Clurman, A.; Slingerland, A. E.; Taur, Y.; Peled, J. U.; Park, J.; O'Cearbhaill, R.; Mailankody, S.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Impact of pre-transplant measurable residual disease on relapse incidence and progression-free survival in older AML/MDS patients following allogeneic hematopoietic cell transplantation
    Meeting Abstract

    Lin, R. J.; Elko, T. A.; Devlin, S. M.; Perales, M. A.; Papadopoulos, E. B.; Castro-Malaspina, H.; Gyurkocza, B.; Shaffer, B. C.; Tamari, R.; Tallman, M.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Cytomegalovirus reactivation promotes CD8+ T cell subset recovery after unmodified allogeneic hematopoietic cell transplantation
    Meeting Abstract

    Jain, T.; Cho, C.; Hilden, P.; Politikos, I.; Borrill, T.; Giralt, S. A.; Maslak, P.; O'Reilly, R. J.; van den Brink, M. R. M.; Perales, M. A.
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Prediction of CAR T-related toxicities in R/R DLBCL patients treated with axicabtagene ciloleucel using point of care cytokine measurements
    Meeting Abstract

    Faramand, R.; Kotani, H.; Morrissey, D.; Yu, B.; Locke, F. L.; Jain, M.; Chavez, J. C.; Wang, X.; Mishra, A.; Bachmeier, C. A.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save